These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 2260057)
1. [Treatment of tuberculosis. Drug combinations, therapeutic problems and results in a 10-year case load]. Morland L Tidsskr Nor Laegeforen; 1990 Nov; 110(28):3608-11. PubMed ID: 2260057 [TBL] [Abstract][Full Text] [Related]
2. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [TBL] [Abstract][Full Text] [Related]
3. Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report. Teo SK Int J Tuberc Lung Dis; 1999 Feb; 3(2):126-32. PubMed ID: 10091877 [TBL] [Abstract][Full Text] [Related]
4. [Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years]. Brändli O; Haegi V; Villiger B; Bohn W; Baumann HR; Zäch R Schweiz Med Wochenschr; 1989 Mar; 119(10):299-305. PubMed ID: 2652281 [TBL] [Abstract][Full Text] [Related]
5. Fixed-dose combination chemotherapy (Rifater/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up. Su WJ; Perng RP Int J Tuberc Lung Dis; 2002 Nov; 6(11):1029-32. PubMed ID: 12475151 [TBL] [Abstract][Full Text] [Related]
6. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens. Jawahar MS; Rajaram K; Sivasubramanian S; Paramasivan CN; Chandrasekar K; Kamaludeen MN; Thirithuvathas AJ; Ananthalakshmi V; Prabhakar R Trop Med Int Health; 2005 Nov; 10(11):1090-8. PubMed ID: 16262733 [TBL] [Abstract][Full Text] [Related]
7. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach. Santha T; Rehman F; Mitchison DA; Sarma GR; Reetha AM; Prabhaker R; Trop Med Int Health; 2004 May; 9(5):551-8. PubMed ID: 15117298 [TBL] [Abstract][Full Text] [Related]
8. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis]. Wada M; Yosiyama T; Yosikawa M; Ogata H; Sugie T; Nakasono T; Sugita H Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720 [TBL] [Abstract][Full Text] [Related]
9. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis]. Zierski M; Bek E Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146 [No Abstract] [Full Text] [Related]
10. [The short-term and long-term treatment outcomes in patients with pulmonary tuberculosis positive for drug-resistant and sensitive strains]. Han JP; Sun SL; Li RZ; Zhang FS; Wang SC; Cheng J; Deng YF; Wang Y; Yu CB Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):70-3. PubMed ID: 12783654 [TBL] [Abstract][Full Text] [Related]
11. [Therapeutic trial of a combination of isoniazid, rifampicin and pyrazinamide in the first 2 months of treatment of pulmonary tuberculosis]. Bellabas M; Khaled S; Khaled NA; Boulahbal F; Chaulet P Rev Mal Respir; 1989; 6(1):59-64. PubMed ID: 2648511 [TBL] [Abstract][Full Text] [Related]
12. [Chemotherapy with isoniazid and rifampicin for pulmonary tuberculosis]. Kawakami K Kekkaku; 2002 Aug; 77(8):569-71. PubMed ID: 12235849 [TBL] [Abstract][Full Text] [Related]
13. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda. Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516 [TBL] [Abstract][Full Text] [Related]
14. [Therapy of tuberculosis in the adult]. Schrappe M; Wassermann K; Kroegel C Med Klin (Munich); 1995 Apr; 90(4):229-30. PubMed ID: 7776936 [No Abstract] [Full Text] [Related]
15. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis. Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119 [TBL] [Abstract][Full Text] [Related]
16. Side-effects of drugs used in directly observed treatment short-course in newly diagnosed pulmonary tuberculosis subjects in Nigerians: a controlled clinical study. Dosumu EA Niger Postgrad Med J; 2002 Mar; 9(1):34-7. PubMed ID: 11932759 [TBL] [Abstract][Full Text] [Related]
17. [Controlled study comparing 3 daily chemotherapy regimens for six months in pulmonary tuberculosis in routine practice in Algiers. Results at 30 months]. Mazouni L; Tazir M; Boulahbal F; Chaulet P Rev Mal Respir; 1985; 2(4):209-14. PubMed ID: 3937189 [TBL] [Abstract][Full Text] [Related]
18. [Follow-up observation on relapse of smear negative pulmonary tuberculosis after short-course chemotherapy]. Xu WG; Gao Z; Fan BD Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):74-6. PubMed ID: 12783655 [TBL] [Abstract][Full Text] [Related]
19. Isoniazid induced gynaecomastia: a case report. Garg R; Vaibhav ; Mehra S; Prasad R Indian J Tuberc; 2009 Jan; 56(1):51-4. PubMed ID: 19402273 [TBL] [Abstract][Full Text] [Related]
20. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre. Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]